2025 Environmental, Social, and Governance (ESG) Report
Report Description
The "Environmental, Social, and Governance (ESG) Report 2025" (hereinafter referred to as "this Report") is the fourth ESG report released by Ringpu Bio Co., Ltd. and its subsidiaries (hereinafter referred to as "Ringpu Bio," "the Company," or "we"). This Report presents the Company's practices and performance in the economic, environmental, social, and governance fields with the principles of objectivity, standardization, transparency, and comprehensiveness, to stakeholders.
Report Scope
The information disclosed in this Report covers Ringpu Bio and its subsidiaries, consistent with the scope of Ringpu Bio's consolidated financial statements. Please refer to the "Ringpu Bio Co., Ltd. 2025 Annual Report" for details.
Time Period
This Report is an annual report covering the period from January 1, 2025, to December 31, 2025. To enhance comparability and completeness, some content extends beyond this period.
Basis of Preparation
This Report is prepared in accordance with the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2 — Norms for the Operation of GEM Companies (2025 Revision)," "Shenzhen Stock Exchange GEM Company Self-Regulatory Supervision Guide No. 3 — Sustainable Development Report Preparation," the "China Enterprise Sustainable Development Report Guide (CASS-ESG 6.0)" by the China Enterprise Reform and Development Research Society, the "Global Reporting Initiative (GRI) Standards," and the United Nations Sustainable Development Goals (SDGs), among other mainstream domestic and international standards.
Data Sources and Reliability Assurance
The information and data disclosed in this Report are derived from Ringpu Bio's internal official documents, statistical reports, and annual reports. Where data disclosed in this Report differs from that in Ringpu Bio's 2025 Annual Report, the Annual Report shall prevail. This Report was reviewed and approved by the Board of Directors on March 27, 2026.
Currency
Unless otherwise specified, all amounts in this Report are presented in RMB.
Forward-Looking Statements Disclaimer
Forward-looking statements in this Report, involving future plans, do not constitute substantive commitments by the Company to investors. Investors and related parties should maintain sufficient risk awareness and understand the difference between plans, forecasts, and commitments.
Report Acquisition
This Report is available in electronic format on the Company's website (https://www.ringpu.com/) and the Shenzhen Stock Exchange website (https://www.szse.cn/index/index.html) in simplified Chinese.
Glossary
| Term | Definition |
|---|---|
| Shareholders' Meeting | Shareholders' Meeting of Ringpu Bio Co., Ltd. |
| Board of Directors | Board of Directors of Ringpu Bio Co., Ltd. |
| Ringpu Tianjin | Ringpu (Tianjin) Pharmaceutical Co., Ltd. |
| Airport Branch Company | Ringpu Bio Technology Co., Ltd. Tianjin Airport Economic Area Branch Company |
| Ringpu Gaoke | Ringpu Gaoke (Tianjin) Biotechnology Co., Ltd. |
| Ringpu Baoding | Ringpu (Baoding) Pharmaceutical Co., Ltd. |
| Bohai Animal Husbandry | Bohai Animal Husbandry Industry Joint Research Institute Co., Ltd. |
| Inner Mongolia Ringpu Agriculture | Inner Mongolia Ringpu Agriculture Technology Co., Ltd. |
| Xinjiang Ringpu Epidemic Prevention and Control | Xinjiang Ringpu Animal Epidemic Prevention and Control Services Co., Ltd. |
| Aowei An Tai | Inner Mongolia Aowei An Tai Biotechnology Co., Ltd. |
| Longxiang Pharmaceutical | Hubei Longxiang Pharmaceutical Technology Co., Ltd. |
| South China Bio | Guangzhou South China Agricultural University Animal Biological Products Co., Ltd. |
| Shanxi Ringxiang Bio | Shanxi Ringxiang Pharmaceutical Co., Ltd. |
| Ringpu Dadi | Inner Mongolia Ringpu Dadi Pharmaceutical Co., Ltd. |
| Zhongrui Supply Chain | Tianjin Zhongrui Supply Chain Management Co., Ltd. |
| Ringpai Pet Hospital | Ringpai Pet Hospital Management Co., Ltd. |
| Ruibao Fund | Tianjin Ruibao Equity Investment Partnership (Limited Partnership) |